The competitive landscape of the ARMD market in 2025 is dominated by a few key players and a leading product. Eylea, a therapy for age-related molecular degeneration, is projected to command a ...

Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis.

In a fresh update, Bloomberg has reported that US biotech Amgen Inc. has agreed to purchase Dublin-based Horizon Therapeutics Plc. for €24.7 billion ($26bn), in a deal which could yet see ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Medical Research News. Health news on everything from cancer to nutrition. Updated daily.

CME activities, cases, challenges, videos, and more teaching and learning tools from the New England Journal of Medicine.

See the latest Packaging Corp of America stock price (PKG:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

WebMD explains various medications for osteoarthritis pain relief, including NSAIDs, corticosteroid injections, and hyaluronic acid treatments. Learn about their benefits and risks.

Nanomedicine articles from across Nature Portfolio Atom RSS Feed Nanomedicine is a branch of medicine that applies the knowledge and tools of nanotechnology to the prevention and treatment of disease.

See the latest Roche Holding AG stock price (ROG:XSWX), related news, valuation, dividends and more to help you make your investing decisions.

Find the latest Amgen Inc. (AMGN) stock quote, history, news and other vital information to help you with your stock trading and investing.

Read the latest research on a wide variety of current medical topics, ranging from birth control and human biology to gene therapy and stem cells. Updated daily.